Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
cystic fibrosis
Research
Carl June, Vertex execs among 2024's Breakthrough Prize winners
CAR-T cell therapy pioneer Carl June, M.D. and scientists from Vertex Pharmaceuticals are among the life sciences winners of 2024 Breakthrough Prizes.
Helen Floersh
Sep 15, 2023 8:00am
Gut punch: First Wave's challenger to AbbVie fails phase 2 again
Jul 13, 2023 7:51am
AbbVie closes cystic fibrosis chapter after combo 'did not work'
Apr 27, 2023 11:32am
Chiesi, Affibody sign $637M respiratory disease collab
Mar 7, 2023 11:15am
First Wave signs Rho for Phase 2 trial of gastrointestinal drug
Nov 3, 2022 7:00am
Eloxx stock slumps lower on failed phase 2 cystic fibrosis trial
Sep 15, 2022 5:40am
